1 – 10 of 24
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2009
-
Mark
Myometrial oxytocin receptor mRNA concentrations at preterm and term delivery-the influence of external oxytocin
(
- Contribution to journal › Article
- 2008
-
Mark
Endometrial expression of vasopressin, oxytocin and their receptors in patients with primary dysmenorrhoea and healthy volunteers at ovulation.
(
- Contribution to journal › Article
-
Mark
Reproductive hormones in plasma over the menstrual cycle in primary dysmenorrhea compared with healthy subjects.
(
- Contribution to journal › Article
- 2006
-
Mark
Targeting the oxytocin receptor to relax the myometrium.
(
- Contribution to journal › Scientific review
-
Mark
Validation of a test model of induced dysmenorrhea.
(
- Contribution to journal › Article
-
Mark
Intrauterine pressure, ischemia markers, and experienced pain during administration of a vasopressin V1a receptor antagonist in spontaneous and vasopressin-induced dysmenorrhea.
(
- Contribution to journal › Article
-
Mark
Decreased serum level of macrophage inflammatory chemokine-3 beta/CCL19 in preterm labor and delivery
(
- Contribution to journal › Article
- 2005
-
Mark
The effect of relcovaptan (SR 49059), an orally active vasopressin V1a receptor antagonist, on uterine contractions in preterm labor.
(
- Contribution to journal › Article
-
Mark
Recording of biosignals from the human uterus, a basis for the development of new therapies in preterm labour and primary dysmenorrhoea.
2005) Euroregional Conference on Building Information Society in the Healthcare in Euroregion Niemen 50(Suppl. 2). p.7-8(
- Chapter in Book/Report/Conference proceeding › Paper in conference proceeding
- 2004
-
Mark
Inhibitory effects of SR 49059 on oxytocin-and vasopressin-induced uterine contractions in non-pregnant women.
(
- Contribution to journal › Article